China Health and Technology Innovation Capability has significantly improved

Since the 18th National Congress of the Communist Party of China, China's scientific and technological innovation capabilities in the field of health and health have been significantly improved, and a number of important scientific and technological achievements have emerged. Essence

New medicine research and development from imitation to creation, the pharmaceutical industry from large to strong

"In recent years, the health science and technology innovation system and scientific and technological governance capabilities have been continuously strengthened, and the ability of scientific and technological innovation capabilities has been significantly improved." Liu Dengfeng, a supervisory commissioner of the Department of Science and Education of the National Health and Health Commission, introduced that in the field of health and health technology innovation, the National Health and Health Commission has since since 2008. Lead the organization and implement two major technologies: "major new drug creation" and "major infectious diseases such as AIDS and viral hepatitis". It has 80 new drugs approved for listing for special support, which is 16 times before the implementation of the special implementation. The development of new drugs from imitation to innovation, the pharmaceutical industry from large to strong development has driven the level of prevention, diagnosis, treatment, and control of China infectious disease prevention.

Since the 18th National Congress of the Communist Party of China, the construction of China's health and technology innovation system has continuously improved, and industry governance capabilities have continued to improve. In the field of cardiovascular, including 20 common and multi -disease diseases, China has built 50 national clinical medical research centers and built 75 national key laboratories in the biomedical field. Five medical institutions including Beijing Union Hospital have constructed a major scientific and technological infrastructure of medical institutions, and deployed 109 key laboratories for the construction of 109 commissions. The provincial administrative areas were fully covered.

At the same time, China launched the implementation of the medical and health science and technology innovation project of the Chinese Academy of Medical Sciences, established a new mechanism for resource allocation of resource allocation stably supported by the Scientific Research Institute, and improved medical research and management policies such as clinical research, ethical review, scientific research integrity, and transformation of achievements. Study standardized healthy development.

The number of new crown vaccines and the number of varieties at the world are the leading level in the world

Science and technology is a powerful weapon for human struggle with the disease. Since the epidemic of new coronary pneumonia, vaccines, drugs, diagnostic reagents, medical treatment, etc. are inseparable from scientific and technological innovation. Liu Dengfeng introduced that scientific and technological innovation helped China's epidemic prevention and control from various aspects.

Quickly determine the pathogen. Relying on the advantages, advantageous teams, and scientific research capabilities of major special special deployment, China has determined the new crown virus in one week, separated poison strains, stitched out sequences, shared to the world, and obtained the world health organization "with a record of recording short records to identify the short time of records. High evaluation of the preliminary body ".

Quickly develop a series of diagnostic products. During the two weeks of the epidemic, China quickly developed high -sensitivity and specific new coronal virus nucleic acid detection technology, which played a vital role in screening for early diagnosis and positive infection. In the subsequent prevention and control work, it has played a role in responding to input cases and promoting resumption of work and re -production.

In the field of vaccine research and development, China has designed five technological routes, organized a superior team to carry out scientific and technological research, and laid a solid foundation for subsequent new crown vaccines. In the process, China also pioneered the world's first technical standard for production workshop production workshops in high biological safety risk vaccines. With this standard, China can achieve hundreds of millions of new crown vaccine production. As of now, the number of output and varieties of China's new crown vaccine is at the leading level of the world. Nine vaccines have been approved by the State Drug Administration to be listed or used for emergency use, and three emergency collection lists listed in the World Health Organization.

In terms of drug research and development, the platform and teams based on drug screening, vaccine research and development, and clinical evaluation based on major national special accumulated drugs, China quickly promoted the successful listing of neutralized antibodies, chemical drugs and Chinese medicine. The majority of medical and health workers are not afraid of sacrifice and fear of difficulties. They rush to Wuhan for clinical research and diagnosis and treatment plans for drugs and vaccines. "In terms of drugs, neutralize antibodies, new chemical medicines, and Chinese medicine. For example, Azf will have recently obtained the approval of new coronary pneumonia indications, which is included in the ninth edition diagnosis and treatment plan. These are our drug research and development The fresh example of scientific and technological support. "Liu Dengfeng said.

Investing over 600 million yuan to study special medicine for children

The development of children's medication is a worldwide problem. Generally, Chinese children's special medicines are currently short.

Jiang Jiandong, dean of the Academy of Drugs and Chinese Academy of Pharmaceutical Research and Academician of the Chinese Academy of Pharmaceuticals, said that the physiological status of children in different ages is large, and it is difficult to do clinical trials. Therefore, many companies lack R & D driving force. China attaches great importance to the shortage of children's medication and specializes in the development of children's medicine research and development.

According to reports, in order to improve the situation of Chinese children's medication, the National Health and Health Commission has invested more than 600 million yuan to study children's medication through major special projects, and has published 105 drug research plans in 3 batches. The National Health and Health Commission also established the National Children's Medical Center, organized 23 national pediatrics -related units, established the "Chinese Pediatrics Pharmaceutical Clinical Test Cooperation Network" to promote clinical research on drugs.

In recent years, the State Health and Health Commission, the State Drug Administration, the Ministry of Industry and Information Technology and other departments have also jointly promoted the development and production of children's medication. Driven by the strong promotion of national policies, the level of medication for Chinese children has improved significantly. Jiang Jiandong introduced that in 2021, a total of 47 children's medication was approved to be listed, which significantly improved the clinical medication level. 14 of which were included in the approval of priority review and greatly promoted the process of child medication.

For more than ten years, 31 new drugs for malignant tumors have been listed

In recent years, China has made significant progress in the research and development of malignant tumor drugs. Jiang Jiandong introduced that over the past ten years, China's new drug creation has given key layouts on malignant tumors, supports more than 400 projects, and promotes the listing of 31 new drugs. In the past, chemotherapy had great side effects. After more than ten years of hard work, the side effects of the domestic targeted drugs independently developed by China have been reduced a lot. "Like Zabitinib is not only used in China, it can already be exported to the United States. This field has made relatively obvious progress." Jiang Jiandong introduced that vidic drugs are common anticancer drugs for Chinese hospitals. In terms of immunotherapy, there are PD-1 and PD-L1 drugs. For example, after Tripley's listing, China has begun to target immunotherapy, which is also a very important progress.

"A new type of anticancer drug that is combined with antibodies and compounds and more targeted. We call it ADC drugs, such as Vidicu Mighting, which was not available in my country before, and has been approved for listing. "Jiang Jiandong introduced that at present, the malignant tumor drugs in China have reached the stage of clinical comparative comparison. Some innovative drugs have expanded a new anti -cancer mechanism, which may make the side effects of tumor treatment less side effects and less patients with patients. For breast cancer, lung cancer, cerebral gum tumor, lymphoma and other diseases, several drugs can expect patients to serve China in the next few years.

5G, AI and other technologies have great applications in the field of medical fields

At present, high -tech such as 5G and artificial intelligence is constantly emerging. How to make new technologies be better applied to clinical diagnosis and treatment and serve the health of the masses?

In this regard, Wang Chen, dean of the Chinese Academy of Medical Sciences and academicians of the Chinese Academy of Engineering, said that 5G and AI are currently developing technologies with rapid development and close medical applications. In fact, new technologies related to medicine are more than that. Medicine is "more studies". It is necessary to bring together the most cutting -edge and advanced technologies of each discipline to serve human health.

"5G, AI, cloud computing, big data and other rapid development of technology in the field of medical fields are very large." Wang Chen said that due to remote consultation, due to 5G technology, the transmission speed increased significantly, which can be achieve Real -time communication is getting closer to the on -site inspection. Through robots and network operations, doctors can perform remote surgery. These are the medical application of engineering technology, science and technology. In terms of mobile terminal devices, a series of physiological parameters and movements can be collected in real time, and even more detailed exercise, body metabolism, heart rate, and blood pressure data can be collected and analyzed.

"Now a very important trend is to gather innovative technologies to health, because human health has gradually become one of the most important and core needs of people's livelihood." Wang Chen said that in recent years, everyone has experienced this progress. Including the smart watches worn by people, the monitoring of health software, and the healthy interaction and promotion of the crowd. In terms of health promotion, prevention, diagnosis, control, treatment, rehabilitation, etc., AI, 5G, etc. can play an important role.

- END -